Title 21Food and DrugsRelease 119-83

§399j Abraham Accords Office

Title 21 › Chapter CHAPTER 9— - FEDERAL FOOD, DRUG, AND COSMETIC ACT › Subchapter SUBCHAPTER X— - MISCELLANEOUS › § 399j

Last updated Apr 18, 2026|Official source

Summary

The Secretary of Health and Human Services, through the FDA Commissioner, must create an Abraham Accords Office inside the Food and Drug Administration and put a director in charge. Not later than 2 years after February 3, 2026, the Secretary must pick a location for that office in an Abraham Accords country, set it up, and assign FDA staff to work there. The choice must be made with the governments of Abraham Accords countries and relevant U.S. diplomats and security officials. Once open, the office must give technical help to regulators in those countries to improve and align rules for FDA-regulated products (including good manufacturing practices for medical products). It must also help the FDA interact with interested parties in those countries, share information about U.S. regulatory pathways, and get feedback on research, development, and manufacturing. The Secretary can assign other needed duties. Abraham Accords country means a country the State Department says signed the Abraham Accords Declaration. Nothing requires action that would conflict with a federal national security recommendation.

Full Legal Text

Title 21, §399j

Food and Drugs — Source: USLM XML via OLRC

(a)The Secretary, acting through the Commissioner of Food and Drugs, shall establish within the Food and Drug Administration an office, to be known as the Abraham Accords Office, to be headed by a director.
(b)Not later than 2 years after February 3, 2026, the Secretary shall—
(1)in consultation with the governments of Abraham Accords countries, as well as appropriate United States Government diplomatic and security personnel—
(A)select the location of the Abraham Accords Office in an Abraham Accords country; and
(B)establish such office; and
(2)assign to such office such personnel of the Food and Drug Administration as the Secretary determines necessary to carry out the functions of such office.
(c)The Secretary, acting through the Director of the Abraham Accords Office, shall—
(1)after the Abraham Accords Office is established—
(A)as part of the Food and Drug Administration’s work to strengthen the international oversight of regulated commodities, provide technical assistance to regulatory partners in Abraham Accords countries on strengthening regulatory oversight and converging regulatory requirements for the oversight of regulated products, including good manufacturing practices and other issues relevant to manufacturing medical products that are regulated by the Food and Drug Administration; and
(B)facilitate interactions between the Food and Drug Administration and interested parties in Abraham Accords countries, including by sharing relevant information regarding United States regulatory pathways with such parties, and facilitate feedback on the research, development, and manufacturing of products regulated in accordance with this chapter; and
(2)carry out other functions and activities as the Secretary determines to be necessary to carry out this section.
(d)In this section, the term “Abraham Accords country” means a country identified by the Department of State as having signed the Abraham Accords Declaration.
(e)Nothing in this section shall be construed to require any action inconsistent with a national security recommendation provided by the Federal Government.

Legislative History

Notes & Related Subsidiaries

Editorial Notes

Reference

Citations & Metadata

Citation

21 U.S.C. § 399j

Title 21Food and Drugs

Last Updated

Apr 18, 2026

Release point: 119-83